Skip to content

Pitney Bowes PBI Restructuring Costs And Asset Impairment Charges

Restructuring Costs And Asset Impairment Charges at other companies

Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$796K+371%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$0+100%
ALH
Alliance Laundry Holdings Inc.ALH
$0-100%
Enphase Energy logo
Enphase EnergyENPH
$3.83M+21.0%
Kennametal logo
KennametalKMT
$2.12M-62.2%
Sonoco Products logo
Sonoco ProductsSON
$15.13M+11.4%

Other financials

Income statement

See full
Revenue$477.4M-3.2%
Gross profit$271.7M
Net income$58.1M+64.1%
EPS (diluted)$0.39+105%

Balance sheet

See full
Cash & equivalents$86.5M-73.3%
Total debt$2.3B+11.1%
Total equity-$893.6M-66.7%
Total assets$3.1B-3.7%

Cash flow

See full
Operating cash flow$44.2M+365%
CapEx$15.8M-6.2%
Free cash flow$28.3M+184%

Valuation

See full
Market cap$2.35B-0.3%
Enterprise value$4.53B+13.6%
P/E14.1×
P/S1.3×+0.1×

Profitability

See full
Gross margin30.5%
Net margin8.9%+6.0pp
FCF margin20.2%+12.4pp

Returns & leverage

See full
Return on equity11%-80.1pp
Debt / equity41.4×+14.6×
Current ratio0.6×-0.2×

Where this comes from

Reported directly by Pitney Bowes in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCostsAndAssetImpairmentCharges.

The official record: Pitney Bowes’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pitney Bowes's restructuring costs and asset impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pitney Bowes's restructuring costs and asset impairment charges?
Pitney Bowes (PBI) reported restructuring costs and asset impairment charges of $5.11M in Q1 2026.
How has Pitney Bowes's restructuring costs and asset impairment charges changed year-over-year?
Pitney Bowes's restructuring costs and asset impairment charges increased by 265.1% year-over-year, from $1.4M to $5.11M.
What does restructuring costs and asset impairment charges mean?
This metric represents expenses incurred from organizational realignments, workforce reductions, and the write-down of asset values due to impairment. It reflects the costs associated with strategic shifts or operational streamlining efforts intended to improve long-term efficiency. Investors monitor this to assess the impact of transformation initiatives on current earnings and the potential for future cost savings.